Active Substance: Travoprost.
Overview
Welcome to Dwaey, specifically on TRAVATAN 0.004% page.
This medicine contains an important and useful components, as it consists of
Travoprostis available in the market in concentration
Travoprost 0.004% Eye prep
Aphakic patient, pseudophakic patient w/ torn posterior lens capsule or anterior chamber lenses, or w/ known risk factor for cystoid macular oedema. Patient w/ history of intraocular inflammation (e.g. uveitis, iritis). Pregnancy and lactation. Patient Counselling Remove contact lenses prior to admin and reinsert after 15 min. Lactation: distributed in milk in animals; caution if used in nursing women
Ocular hypertension; Open-angle glaucoma
Hypersensitivity, Pregnancy
>10% Increased pigmentation of iris & periorbital tissue & increased pigmentation, thickening, elongation & growth of eyelashes (59%),Ocular hyperemia (35-50%) 1-10% Decreased visual acuity (5-10%),Ocular discomfort (5-10%),Foreign body sensation (5-10%),Pain (5-10%),Pruritus (5-10%),Abnormal vision (1-4%),Blepharitis (1-4%),Blurred vision (1-4%),Cataract (1-4%),Conjunctivitis (1-4%),Dry eye (1-4%),Iris discoloration (1-4%),Keratitis (1-4%),Lid margin crusting (1-4%),Photophobia (1-4%),Subconjunctival hemorrhage (1-4%),Tearing (1-4%)
3
Travoprost, a synthetic analogue of prostaglandin F2?, reduces intraocular pressure by increasing uveoscleral outflow of aqueous humour.
Reduced therapeutic effect w/ NSAIDs.
Information not available